6D1F
Crystal structure of NDM-1 complexed with compound 8
6D1F の概要
エントリーDOI | 10.2210/pdb6d1f/pdb |
分子名称 | Metallo-beta-lactamase type 2, ZINC ION, [(5,7-difluoro-2-oxo-2H-1-benzopyran-4-yl)methyl]phosphonic acid, ... (5 entities in total) |
機能のキーワード | beta-lactamase, carbapenemase, phosphonate, inhibitor, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
由来する生物種 | Klebsiella pneumoniae |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 25127.72 |
構造登録者 | |
主引用文献 | Pemberton, O.A.,Jaishankar, P.,Akhtar, A.,Adams, J.L.,Shaw, L.N.,Renslo, A.R.,Chen, Y. Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases. J.Med.Chem., 62:8480-8496, 2019 Cited by PubMed Abstract: Gram-negative pathogens expressing serine β-lactamases (SBLs) and metallo-β-lactamases (MBLs), especially those with carbapenemase activity, threaten the clinical utility of almost all β-lactam antibiotics. Here we describe the discovery of a heteroaryl phosphonate scaffold that exhibits noncovalent cross-class inhibition of representative carbapenemases, specifically the SBL KPC-2 and the MBLs NDM-1 and VIM-2. The most potent lead, compound , exhibited low nM to low μM inhibition of KPC-2, NDM-1, and VIM-2. Compound potentiated imipenem efficacy against resistant clinical and laboratory bacterial strains expressing carbapenemases while showing some cytotoxicity toward human HEK293T cells only at concentrations above 100 μg/mL. Complex structures with KPC-2, NDM-1, and VIM-2 demonstrate how these inhibitors achieve high binding affinity to both enzyme classes. These findings provide a structurally and mechanistically new scaffold for drug discovery targeting multidrug resistant Gram-negative pathogens and more generally highlight the active site features of carbapenemases that can be leveraged for lead discovery. PubMed: 31483651DOI: 10.1021/acs.jmedchem.9b00728 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.15 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード